Can metformin cause uti

Pro Research Analysisby

Searched over 200M research papers

Analyzed relevant papers

Can Metformin Cause Urinary Tract Infections (UTIs)?

Metformin and UTI Risk in Type 2 Diabetes Patients

Overview of Metformin Use in Diabetes Management

Metformin is a widely prescribed medication for managing type 2 diabetes (T2DM). It is often the first-line treatment due to its efficacy in lowering blood glucose levels and its relatively favorable safety profile. However, concerns about potential side effects, including the risk of urinary tract infections (UTIs), have been raised.

Comparative Studies on UTI Risk

A comprehensive study analyzed data from 40,774 patients with T2DM to compare the incidence of UTIs between metformin users and nonusers. The results indicated no significant difference in the risk of developing UTIs between the two groups. Specifically, the adjusted hazard ratios (aHRs) for UTI and recurrent UTI in metformin users were 1.06 and 1.08, respectively, which are not statistically significant compared to nonusers . This suggests that metformin does not increase the risk of UTIs in patients with T2DM.

Mortality and Severe Outcomes Related to UTIs

Interestingly, the same study found that metformin use was associated with a significantly lower risk of death due to UTI or sepsis. The cumulative incidence of death due to these conditions was notably lower in metformin users compared to nonusers (p = 0.002). This protective effect was more pronounced with longer cumulative durations of metformin use . Therefore, while metformin does not increase the risk of UTIs, it may contribute to better survival outcomes in severe cases.

Adjunctive Antidiabetic Therapies and UTI Risk

Another study evaluated the safety and efficacy of various antidiabetic agents added to metformin monotherapy. This network meta-analysis included 62 trials and assessed the risk of UTIs among other outcomes. The findings revealed that no adjunctive therapy, including those combined with metformin, increased the risk of UTIs compared to placebo . This further supports the notion that metformin, whether used alone or in combination with other antidiabetic drugs, does not elevate the risk of UTIs.

Conclusion

Current research indicates that metformin does not increase the risk of urinary tract infections in patients with type 2 diabetes. Moreover, metformin use is associated with a lower risk of mortality from severe infections like UTIs and sepsis. These findings suggest that metformin remains a safe and effective option for managing T2DM without contributing to an increased risk of UTIs.

Sources and full results

Most relevant research papers on this topic

Role of Metformin in Morbidity and Mortality Associated with Urinary Tract Infections in Patients with Type 2 Diabetes

Metformin use in patients with type 2 diabetes is associated with a lower risk of death due to urinary tract infections or sepsis compared to nonuse.

Observational StudyRigorous Journal

2022·

4citations

·F. Yen et al.

Comparative Efficacy and Safety of Antidiabetic Drug Regimens Added to Metformin Monotherapy in Patients with Type 2 Diabetes: A Network Meta-Analysis

Adding different antidiabetic agents to metformin can have varying effects on HbA1c, BW, SBP, hypoglycemia, UTI, and GTI, impacting clinician choice when selecting adjunctive therapy.

Meta-AnalysisRigorous JournalHighly Cited

2015·

125citations

·Elizabeth S. Mearns et al.

Is metformin poised for a second career as an antimicrobial?

Metformin shows potential as an antimicrobial agent, improving outcomes in patients with tuberculosis and a wide range of other infections.

Systematic ReviewHighly Cited

2018·

71citations

·Faiza Malik et al.

Metformin and Its Benefits for Various Diseases

Metformin offers benefits for various diseases and aging, with potential underlying mechanisms still unclear.

Highly Cited

2020·

287citations

·Ziquan Lv et al.

Metformin as Anti-Aging Therapy: Is It for Everyone?

Metformin shows potential in retarding aging and reducing aging-related diseases, but its mechanisms and side effects need further study before it becomes a mainstay anti-aging therapy.

Literature ReviewHighly Cited

2019·

161citations

·A. Soukas et al.

The mechanisms of action of metformin

Metformin improves glucose metabolism and diabetes-related complications through multiple mechanisms, including reducing hepatic glucose production and a key role for the gut.

Rigorous JournalHighly Cited

2017·

1571citations

·G. Rena et al.

Metformin-associated lactic acidosis: Current perspectives on causes and risk.

Metformin-associated lactic acidosis (MALA) is a rare but potentially fatal condition in type 2 diabetes patients, with current renal function cutoffs potentially being too conservative.

Literature ReviewHighly Cited

2016·

484citations

·R. DeFronzo et al.

Metformin in cancer.

Metformin may have potential anti-tumorgenic effects, but its effectiveness in treating cancer remains inconclusive.

Highly Cited

2018·

173citations

·Ritwika Mallik et al.

A Comprehensive Review of Drug–Drug Interactions with Metformin

Metformin's mechanism of action and pharmacokinetic pathway remain unclear, leading to drug-drug interactions and highlighting the need for future studies to focus on pharmacodynamic endpoints and pharmacogenetic variation.

Literature ReviewVery Rigorous JournalHighly Cited

2015·

70citations

·T. Stage et al.

Metformin and Aging: A Review

Metformin may be an "anti-aging" drug, but concerns exist about vitamin B12 and B6 deficiencies and potential adverse effects on cardiovascular fitness from exercise.

Literature ReviewHighly Cited

2019·

104citations

·H. Glossmann et al.

Try another search

depression medication list

adjustment disorder with mixed anxiety and depressed mood

hydrochlorothiazide 25 mg used for

most recommended antidepressant

disorder of thinking

manic vs hypomanic